Menopause. Menopausal and other perimenopausal disorders
Conditions
Interventions
Intervention 1: Intervention group: Patients in the intervention group were treated with one third of 4 gr applicator of vaginal cream 0.625mg estrogen conjugate (each 1gr contains 0.625 mg conjugate
Sponsors
Iran University of Medical Sciences
Eligibility
Sex/Gender
Female
Inclusion criteria
Inclusion criteria: Postmenopausal women (at least more than 1 year after the last menstrual cycle) Candidates for hysteroscopy Patients must have a normal mammogram and Pap smear within the last 2 years
Exclusion criteria
Exclusion criteria: Recent or current pelvic infection History of cervical conization Previous surgery on the cervix hypersensitivity to prostaglandins History of venous thrombosis Cardiovascular disease Cervical or breast malignancies Mullerian anomaly Cervical anomalies
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Hegar cervical dilator during hysteroscopy. Timepoint: One during hysteroscopy. Method of measurement: Observation. | — |
Secondary
| Measure | Time frame |
|---|---|
| Cervical softness and stenosis. Timepoint: One during hysteroscopy. Method of measurement: Observation.;Pain. Timepoint: One 6 hours after hysteroscopy. Method of measurement: Visual analogue scale. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactMahsa Kiani
Iran University of Medical Sciences
Outcome results
None listed